4//SEC Filing
Immune Design Corp. 4
Accession 0001123292-15-000123
CIK 0001437786operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:22 PM ET
Size
7.0 KB
Accession
0001123292-15-000123
Insider Transaction Report
Form 4
PENHOET EDWARD
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2015-01-07+9,300→ 9,300 totalExercise: $31.00Exp: 2025-01-07→ Common Stock (9,300 underlying)
Holdings
- 2,482,775(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]All shares of common stock held by the Reporting Person are subject to a 180-day lockup agreement entered into by the Reporting Person in connection with the Issuer's initial public offering.
- [F2]The securities are directly held by Alta Partners VIII, L.P. ("Alta Partners"). Dr. Penhoet is a director of Alta Partners and may be deemed to have beneficial ownership of shares Alta Partners' interest in the Issuer. Dr. Penhoet disclaims beneficial ownership of shares held by entities affiliated with Alta Partners, except to the extent of his pecuniary interest therein.
- [F3]The shares issuable upon exercise of the options to purchase common stock held by the Reporting Person are subject to a 180-day lockup agreement entered into by the Reporting Person in connection with the Issuer's initial public offering.
- [F4]The shares underlying the options will become fully vested on January 1, 2016.
Documents
Issuer
Immune Design Corp.
CIK 0001437786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001437786
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:22 PM ET
- Size
- 7.0 KB